Inhibitor tamps down TGF-beta1 and rejuvenates aging stem cells in brain and muscles
Whether you’re brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue.
Researchers at the University of California, Berkeley, have discovered that a small-molecule drug simultaneously perks up old stem cells in the brains and muscles of mice, a finding that could lead to drug interventions for humans that would make aging tissues throughout the body act young again.
“We established that you can use a single small molecule to rescue essential function in not only aged brain tissue but aged muscle,” said co-author David Schaffer, director of the Berkeley Stem Cell Center and a professor of chemical and biomolecular engineering. “That is good news, because if every tissue had a different molecular mechanism for aging, we wouldn’t be able to have a single intervention that rescues the function of multiple tissues.”
The drug interferes with the activity of a growth factor, transforming growth factor beta 1 (TGF-beta1), that Schaffer’s UC Berkeley colleague Irina Conboy showed over the past 10 years depresses the ability of various types of stem cells to renew tissue.
“Based on our earlier papers, the TGF-beta1 pathway seemed to be one of the main culprits in multi-tissue aging,” said Conboy, an associate professor of bioengineering. “That one protein, when upregulated, ages multiple stem cells in distinct organs, such as the brain, pancreas, heart and muscle. This is really the first demonstration that we can find a drug that makes the key TGF-beta1 pathway, which is elevated by aging, behave younger, thereby rejuvenating multiple organ systems.”
The UC Berkeley team reported its results in the current issue of the journal Oncotarget. Conboy and Schaffer are members of a consortium of faculty who study aging within the California Institute for Quantitative Biosciences (QB3).
Depressed stem cells lead to aging
Aging is ascribed, in part, to the failure of adult stem cells to generate replacements for damaged cells and thus repair the body’s tissues. Researchers have shown that this decreased stem cell activity is largely a result of inhibitory chemicals in the environment around the stem cell, some of them dumped there by the immune system as a result of chronic, low-level inflammation that is also a hallmark of aging.
In 2005, Conboy and her colleagues infused old mice with blood from young mice – a process called parabiosis – reinvigorating stem cells in the muscle, liver and brain/hippocampus and showing that the chemicals in young blood can actually rejuvenate the chemical environment of aging stem cells. Last year, doctors began a small trial to determine whether blood plasma from young people can help reverse brain damage in elderly Alzheimer’s patients.
Such therapies are impractical if not dangerous, however, so Conboy, Schaffer and others are trying to track down the specific chemicals that can be used safely and sustainably for maintaining the youthful environment for stem cells in many organs. One key chemical target for the multi-tissue rejuvenation is TGF-beta1, which tends to increase with age in all tissues of the body and which Conboy showed depresses stem cell activity when present at high levels.
Five years ago, Schaffer, who studies neural stem cells in the brain, teamed up with Conboy to look at TGF-beta1 activity in the hippocampus, an area of the brain important in memory and learning. Among the hallmarks of aging are a decline in learning, cognition and memory. In the new study, they showed that in old mice, the hippocampus has increased levels of TGF-beta1 similar to the levels in the bloodstream and other old tissue.
Using a viral vector that Schaffer developed for gene therapy, the team inserted genetic blockers into the brains of old mice to knock down TGF-beta1 activity, and found that hippocampal stem cells began to act more youthful, generating new nerve cells.
Drug makes old tissue cleverer
The team then injected into the blood a chemical known to block the TGF-beta1 receptor and thus reduce the effect of TGF-beta1. This small molecule, an Alk5 kinase inhibitor already undergoing trials as an anticancer agent, successfully renewed stem cell function in both brain and muscle tissue of the same old animal, potentially making it stronger and more clever, Conboy said.
“The key TGF-beta1 regulatory pathway became reset to its young signaling levels, which also reduced tissue inflammation, hence promoting a more favorable environment for stem cell signaling,” she said. “You can simultaneously improve tissue repair and maintenance repair in completely different organs, muscle and brain.”
Read more: Drug perks up old muscles and aging brains
The Latest on: Reversing aging
[google_news title=”” keyword=”Reversing aging” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Reversing aging
- ‘Menopause Makeovers’ on the rise as more women attempt to fight effects of agingon May 6, 2024 at 6:19 pm
Is it a shift in culture, price, or medical reasons? Reporter Jen Picciano explains why women are lining up for a menopause makeover.
- Announcing OneSkin as Tier 5 Sponsor of ARDD 2024on May 6, 2024 at 8:27 am
“The upcoming 5th Longevity Medicine and XPRIZE Healthspan Team Summit at ARDD, marks a significant milestone in the integration of cutting-edge geroscience and AI into clinical practice, with a focus ...
- Announcing Aging as Tier 5 Sponsor of ARDD 2024on May 5, 2024 at 5:00 pm
The University of Copenhagen is excited to announce Aging as a Tier 5 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the ...
- Reverse aging pioneer to speak on turning back the hands of time with scientifically proven age reversal methodson April 30, 2024 at 4:30 am
Life Extension Foundation co-founder and reverse aging pioneer Bill Faloon will speak to the realities of what leads to the aging process and how it can be reversed when he ...
- Around The Bluhmin' Town: Reversing the aging process is a winneron April 30, 2024 at 12:00 am
Do you want to live forever? Nope, I didn’t think so. Me either. Although prolonging (a quality) life sounds pretty good. Then there are those among us who are determined ...
- Reverse aging pioneer to address Old Fort Bay clubon April 29, 2024 at 10:58 am
# Reverse aging pioneer, lecturer and author Bill Faloon is slated to speak at the Old Fort Bay Club on Wednesday. # Mr Faloon is 69, but claims his biological vitals are those of a 53-year-old. He ...
- A longevity researcher is facing backlash for claiming to 'reverse aging.' Scientists say there's no consensus on what it means.on April 28, 2024 at 3:00 pm
Sinclair has been a poster child of the longevity movement for years. He's built several biotechnology companies focused on reversing the effects of aging, won acclaim for his research, and cultivated ...
- A longevity researcher is facing backlash for claiming to 'reverse aging.' Scientists say there's no consensus on what it means.on April 28, 2024 at 2:43 pm
He's built several biotechnology companies focused on reversing the effects of aging, won acclaim for his research, and cultivated a loyal base of fans who swear by his lifestyle tips. He's also ...
- Star scientist’s claim of ‘reverse aging’ draws hail of criticismon April 28, 2024 at 2:29 pm
His dog-supplement company, Animal Biosciences, issued a reworded press release backing away from the claim of reversing aging. The search for eternal youth has fueled a longevity industry that ...
- Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticismon April 27, 2024 at 6:00 pm
He has parlayed his research into hundreds of millions of dollars of investment in various companies, more than 50 patents and prominence as a longevity influencer.Along the way, his claims—especially ...
via Bing News